Sentinel Lymph Node Status

Sentinel Lymph Node Status is a clinical prognostic indicator that denotes the presence or absence of metastatic cancer cells in the sentinel lymph node, the first lymph node to which cancer is likely to spread from a primary tumor, thereby guiding staging and treatment decisions in breast cancer recurrence.

2.9K

Publications

174.8K

Citations

14K

Authors

2.7K

Institutions

Publications per year

2017–2026

591

Variants

Sentinel Node Status

Authors

14K

  1. KK
    Kelly K. Hunt

    The University of Texas MD Anderson Cancer Center, United States

    54 publications · 7.9K citations

    44

    h-index

  2. MI
    Merrick I. Ross

    The University of Texas MD Anderson Cancer Center, United States

    43 publications · 5.5K citations

    34

    h-index

  3. HM
    Henry M. Kuerer

    The University of Texas MD Anderson Cancer Center, United States

    37 publications · 4.5K citations

    32

    h-index

  4. HS
    Hiram S. Cody

    Memorial Sloan Kettering Cancer Center, United States

    39 publications · 5.6K citations

    29

    h-index

  5. KM
    Kelly M. McMasters

    University of Louisville, United States

    41 publications · 4.1K citations

    28

    h-index

1–5 of 14K

Venues

  1. Annals of Surgical Oncology

    436 publications · 26.6K citations

    84

    h-index

  2. Journal of Clinical Oncology

    64 publications · 16.5K citations

    51

    h-index

  3. Gynecologic Oncology

    92 publications · 7.1K citations

    48

    h-index

  4. Breast Cancer Research and Treatment

    107 publications · 6.5K citations

    46

    h-index

  5. European Journal of Surgical Oncology

    EJSO · 156 publications · 6.6K citations

    45

    h-index

1–5